by Jonathan Warnock, CMO Beuhi
With the rising interest in alternative symptom relief using herbal medicines (i.e. echinacea, St. Johns’ Wort, and ginseng), CBD, and cannabis as a treatment for certain chronic care symptoms, caregivers and healthcare providers are exploring how botanical compounds may alleviate issues like agitation, anxiety, sleep disturbances, and pain. For example, in treating symptoms for dementia patients, traditionally, antipsychotic medications have been the mainstay, yet they often come with side effects like confusion and drowsiness that can further impair cognition. Cannabis, however, is emerging as an alternative that, while not without risks, offers a potentially gentler option for many elderly patients. Sumathi Reddy from The Wall Street Journal recently reported, Dr. Jeffrey Hergenrather, a physician specializing in cannabis, and other experts have noted its calming effects on dementia-related agitation, often enabling patients to rest more easily and experience reduced anxiety. But how can we balance the potential benefits of using any botanical with a level of safety and control suited to dementia and other chronic care?
This is where Beuhi’s candy-making appliance and digital platform can make a significant impact, as it offers the precision, data, and safety features to transform alternative symptom relief treatments into a tailored experience that is both manageable and effective.
Precision and Control: Beuhi’s Role in Safe, Personalized Dosing
A primary advantage Beuhi offers caregivers is precision in botanical and nutraceuticals (including cannabis) dosing. For elderly patients, where tolerance and sensitivity to THC and CBD can vary greatly, a controlled and consistent dose is essential. Beuhi’s system allows users to produce candies with personalized doses in familiar formats like gummies and chocolates, making consumption easy and safe for elderly patients who may struggle with vaping, smoking, swallowing pills or other forms of ingestion. Moreover, Beuhi enables caregivers to monitor and adjust the ratios of the preferred botanical in real time via its mobile app, ensuring that each patient receives the optimal blend for their needs. For example, CBD, known to reduce THC’s psychoactive effects, can be combined with THC in the Beuhi appliance then adjusted as necessary to limit side effects while maximizing benefits like reduced agitation and better sleep. Giving caregivers, their patients, and any user of the Beuhi system total control to personalize their confections for achieving the right balance is one of the most unique features and benefits of our solution.
Beuhi’s App-Based Monitoring and Dosing Control
One of Beuhi’s standout features is the app’s customizable dosing control. Once a desired dosage and output quantity has been set, Beuhi’s app not only provides accurate calculations for adding the correct amount of the botanical to be infused but also offers dosing history and consumption tracking, which enables users to observe patterns and identify any adverse effects. This level of transparency and data collection allows Beuhi users to make informed decisions on treatment adjustments based on their body’s response.
Data-Driven Personalization in Chronic Care
One of the most exciting aspects of Beuhi is its ability to transform data into actionable insights. By gathering information on patient responses to various THC and CBD ratios, dosing times, and symptom improvements, Beuhi can develop a comprehensive profile for each user. This profile allows for a truly individualized approach, where specific symptom trends or emerging side effects can prompt timely adjustments and recommendations prior to creating their next batch of confections.
Looking ahead, integrating AI into Beuhi’s app could further enhance the personalization process. By analyzing patterns in user data, AI could potentially make dosing recommendations, predict which formulations might yield the best results, and even proactively alert users to emerging needs or risks, such as increased drowsiness. This would not only reduce trial and error in finding the optimal botanical combination or dose but could also provide users with peace of mind, knowing that an AI-assisted system is continuously assessing the best ways to deliver comfort and care.
Safety First: Reducing the Risks
A core concern in cannabis use for many is the risk of side effects, particularly drowsiness, which can increase the likelihood of unnecessary accidents. Here, Beuhi’s app plays a crucial role in maintaining safety. Through real-time monitoring during the confection creation process, users can be notified of irregularities or potential hazards like excessive drowsiness based on the collected personal and community data using similar botanicals at certain combinations or quantities. Users or caregivers will be able to journal and track how each candy impacts their mood, motor skills, and other effects. Beuhi could also incorporate alerts for sudden changes in behavior that may indicate over-sedation or adverse effects, allowing users or caregivers to adjust as needed to prevent accidents and maintain quality of life.
Meeting Demand in Nontraditional Solutions
With the growing need for nontraditional care solutions, Beuhi is positioned to serve a unique market of families seeking manageable, safe, and effective solutions for their loved ones. By addressing the need for nontraditional options with a focus on ease of use and safety, Beuhi could become a trusted choice for personalized non-inhalation cannabis therapies.
Beuhi plans to also leverage its app to build a community and provide resources, including educational material on cannabis use, tips on administration, and updates on the latest research through their partnerships with Bennibas Health and Plesio Health/Acute on Chronic. Such resources would empower caregivers to make informed choices, helping them feel confident in their approach to alternative treatment options.
How Beuhi’s Technology Is Transforming Custom Care
As interest in alternative care treatment grows, Beuhi offers a solution that maximizes both safety and effectiveness. By combining personalized dosing, real-time monitoring, and robust data insights, Beuhi addresses the core challenges in custom care, supporting users and caregivers in a way that enhances quality of life while minimizing risks. With the potential for AI integration and a focus on personalization, Beuhi not only provides immediate benefits but also is uniquely suited to redefine how we approach adjacent treatments in the future, bringing hope and comfort to patients and their families alike.
Are you ready for this innovation in your life? You now have a unique opportunity in helping bring Beuhi to market. Beuhi is staying focused and deliberate on the path ahead as we steadily push forward on our Wefunder investment campaign.
For investment information, please visit the link at the top of the page. Our journey has just started, and your investment helps put us that much closer to our goal.